Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT03443947Not ApplicableUnknown

Modified Mallampati Scoring Technique for Airway Assessment

Role: lead

NCT03006640Not ApplicableCompleted

Subcutaneous NTG for US Radial Artery Cannulation

Role: lead

NCT02708459Not ApplicableCompleted

Transversus Abdominus Plane Block in Living Donor Hepatectomy

Role: lead

NCT02553057Not ApplicableUnknown

Low Tidal Volume for Lung Protection During Anesthesia of Laparoscopic Surgery in Trendlenburg Position

Role: lead

NCT02544906Not ApplicableUnknown

Propofol Versus Dexmedetomidine for Prevention of Sevoflurane Agitation in Recipients of Living Donor Liver Transplantation

Role: lead

NCT02521584Unknown

Ischemia Time and Graft Survival

Role: lead

All 6 trials loaded